Latest Vaccination Stories
Alliance to provide vaccines for 5,000 Children and increase awareness of Child Vaccinations RALEIGH, N.C., Dec.
MERIDEN, Conn. and AKITA, Japan, Dec.
Researchers have reportedly developed the first successful vaccination against a condition similar to Mad Cow Disease that affects deer – a discovery that could not only help prevent US livestock from contracting the ailment, but could help prevent similar infections in humans.
SAN DIEGO, Dec. 22, 2014 /PRNewswire/ -- Pfenex Inc.
Immunomic Therapeutics, Inc., (ITI), and Bioject have entered into an agreement for ITI to use Bioject’s Biojector®-2000 needle-free injection device with its LAMP™ vaccine platform.
According to the new report from BCC Research, the global market for cancer vaccines is expected to grow to $4.3 billion by 2019, with a five-year compound annual growth rate (CAGR) of 1.3%.
The secret to combating AIDS and the HIV virus could lie in one of the last places you would ever think to look: the immune systems of llamas.
PARIS, December 18, 2014 /PRNewswire/ -- ABIVAX, a leading clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, is pleased
LOS ANGELES, Dec. 17, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
VGXI announces the expansion of its state-of-the-art cGMP manufacturing facility, located in The Woodlands, TX. The Woodlands, TX (PRWEB) December 15, 2014
The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...
- Growing in low tufty patches.